Wai Chun Biotechnology (00660) appoints Lam Kai-ki as company secretary and authorized representative

Zhitong Finance App News, Wei Jun Biotechnology (00660) announced that Li Huifang has resigned as the company's company secretary and no longer serves as the company's authorized representative. Lin Qiji has been appointed as the company's secretary and authorized representative, effective March 28, 2024.

Zhitong FinanceMar 28 07:55 ET

WAI CHUN BIOTEC: Interim Report 2023/24

Futu NewsMar 27 04:41 ET · Announcements

Wai Chun Bio-Technology's Fiscal H1 Attributable Loss Narrows

Wai Chun Bio-Technology's (HKG:0660) attributable loss narrowed to HK$6.7 million, or HK$0.0393 per share, in the half-year ended Dec. 31, 2023, from HK$7.8 million, or HK$0.0457 per share, in the yea

MT NewswiresMar 1 04:34 ET

Weijun Biotechnology (00660) announced interim results. Shareholders' share loss of HK$6.734 million narrowed 14.01% year-on-year

According to the Zhitong Finance App, Weijun Biotechnology (00660) announced results for the six months ended December 31, 2023. The group achieved revenue of HK$190 million during the period, a year-on-year decrease of 53.01%; the loss due to company owners during the period was HK$6.734 million, a year-on-year decrease of 14.01%; the basic loss per share was HK$3.93. According to the announcement, the decline in revenue was due to a decrease in market consumption and demand during the period.

Zhitong FinanceFeb 29 04:28 ET

WAI CHUN BIOTEC: INTERIM RESULTS FOR THE SIX MONTHSENDED 31 DECEMBER 2023

Futu NewsFeb 29 04:24 ET · Announcements

Weijun Biotechnology (00660.HK) will hold a board meeting on February 29 to approve the interim results

Gelonghui, Feb. 19 | Weijun Biotechnology (00660.HK) announced that the company will hold a board meeting on February 29, 2024 to consider and approve the unaudited interim results announcement and release of the company and its subsidiaries for the six months ended December 31, 2023.

Gelonghui FinanceFeb 19 08:22 ET